Takeda Pharmaceutical Company Limited American Depositary Shares (each (NY:TAK)

17.86 UNCHANGED

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Takeda Pharmaceutical Company Limited American Depositary Shares (each

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Dreary Day ↗

June 14, 2021

Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.

Via Talk Markets

The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs ↗

June 13, 2021

Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in the form of approval...

Via Talk Markets

The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs ↗

June 13, 2021

Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in...

Via Benzinga

Unheeding Markets ↗

June 10, 2021

Today oil prices rose over $70.

Via Talk Markets

Vertex Pharma Stumbles In Rare-Disease Effort, Buoying Rival Arrowhead Pharma ↗

June 10, 2021

Vertex Pharmaceuticals scrapped development of a rare-disease treatment Thursday that appeared unlikely to benefit patients, and VRTX stock plunged.

Via Investor's Business Daily

Blueprint for Access to Innovative Healthcare Episode 1: Awareness and Prevention

June 10, 2021

SOURCE: Takeda

Via 3BL Media

Wednesday News And Catch-Up ↗

June 09, 2021

Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA.

Via Talk Markets

Topics Stocks

Global Diversity, Equity, and Inclusion Week at Takeda

June 08, 2021

SOURCE: Takeda

Via 3BL Media

Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

June 07, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

How Significant Are Moderna's Asian Regulatory Wins? ↗

June 05, 2021

The biotech is poised to profit in both Japan and South Korea.

Via The Motley Fool

A Better Switch ↗

June 04, 2021

Today the US market decided to rise because President Biden is pondering not linking his infrastructure project to a corporate tax increase.

Via Talk Markets

Fan Hit ↗

June 03, 2021

The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares.

Via Talk Markets

Wonder Products ↗

June 02, 2021

Meme is alive and well.

Via Talk Markets

Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates ↗

June 01, 2021

The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive...

Via Benzinga

New New Deal Worries ↗

May 27, 2021

Nio is up 1.4% today on another round of Meme buying.

Via Talk Markets

Good Times For Gold ↗

May 26, 2021

Gold is rising some more, in part as an alternative to crypto.

Via Talk Markets

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

Takeda's Dengue Vaccine Effective In Reducing Hospitalization Regardless Of Prior Infection ↗

May 24, 2021

Takeda Pharmaceutical Co Ltd (NYSE: TAK) unveiled long-term data for its dengue vaccine candidate (TAK-003), showing the shot’s efficacy waned over time but...

Via Benzinga

Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results

May 22, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Worldwide Upbeat ↗

May 21, 2021

The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.

Via Talk Markets

Topics Economy

Takeda's Maribavir US Application For Post-Transplant CMV Infection Under Review ↗

May 21, 2021

The FDA has accepted for review Takeda Pharmaceutical Co Ltd's (NYSE TAK) marketing application for maribavir for cytomegalovirus (CMV) Infection. The...

Via Benzinga

Moderna's COVID-19 Vaccine Scores Emergency Use Nod In Japan ↗

May 21, 2021

Moderna Inc (NASDAQ: MRNA) has received emergency use approval for its mRNA COVID-19 vaccine in Japan. Takeda Pharmaceutical Co Ltd (NYSE: TAK),...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

Is BioCryst a Good Stock to Buy Now? ↗

May 21, 2021

This commercial-stage drugmaker trades for less than many of its clinical-stage peers.

Via The Motley Fool

U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment

May 21, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Takeda Announces Approval of Moderna’s COVID-19 Vaccine in Japan

May 21, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Better Mood Day ↗

May 20, 2021

The US Treasury plans to require IRS reporting on US cryptocurrency trades of $10,000 and up to prevent tax evasion.

Via Talk Markets

Takeda to Present Positive Primary Analysis from Phase 2 OPTIC Trial of ICLUSIG® (ponatinib), Reinforcing Ability to Address Gaps in Care for Chronic-Phase CML

May 19, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Takeda Presents Updated Results for Mobocertinib, Further Substantiating the Clinical Benefit in Patients with EGFR Exon20 Insertion+ mNSCLC

May 19, 2021

From Takeda Pharmaceutical Company Limited

Via Business Wire

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗

May 14, 2021

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.